Search Videos by Topic or Participant
Browse by Series:

Team Approach to Lung Cancer Care Is Essential

Lecia V. Sequist, MD, MPH, Harvard and Corey J. Langer, MD, University Pennsylvania
Published: Monday, Apr 06, 2015
For High-Definition, Click
The proper treatment of patients with lung cancer is dependent on a team approach, emphasizes Corey J. Langer, MD. Adequate sampling and testing requires collaboration between medical oncologists, surgeons, radiologists, and thoracic pathologists. Targeted therapies have also increased the involvement of other specialties, including interventional pulmonology and interventional radiology.

With the growing number of specialists involved in the treatment of patients with lung cancer, oncologist must make it clear which tests are needed to ensure that tissue is appropriately prepared and processed, Langer notes. Moreover, the role of nurses and other support staff remains an important piece of the care continuum, particularly for their role in the education of patients and side effect monitoring.
Slider Left
Slider Right
For High-Definition, Click
The proper treatment of patients with lung cancer is dependent on a team approach, emphasizes Corey J. Langer, MD. Adequate sampling and testing requires collaboration between medical oncologists, surgeons, radiologists, and thoracic pathologists. Targeted therapies have also increased the involvement of other specialties, including interventional pulmonology and interventional radiology.

With the growing number of specialists involved in the treatment of patients with lung cancer, oncologist must make it clear which tests are needed to ensure that tissue is appropriately prepared and processed, Langer notes. Moreover, the role of nurses and other support staff remains an important piece of the care continuum, particularly for their role in the education of patients and side effect monitoring.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: ALK-Positive NSCLC: Emerging Strategies to Inform Sequencing, Optimize Outcomes, and Address Unmet Clinical Needs Along the Disease ContinuumAug 29, 20181.5
Community Practice Connections™: Oncogenic Tumor Board in Advanced NSCLC: Leveraging Actionable Mutations Along the Disease Continuum to Optimize Patient OutcomesAug 30, 20182.0
Publication Bottom Border
Border Publication
x